ICYMI, some of this week’s featured content includes coverage from the ABM Perspectives symposium, a new device cleared for the treatment of wrinkles, an update on the benzene contamination in sunscreens, and more.
Opening the symposium in a circle of sparks and salsa dancing, Shino Bay Aguilera, MD, talks the importance of diversity and wellness in aesthetics.
Victor Ross, MD, board-certified dermatologist and dermatologic surgeon in San Diego, California, spoke about different technologies available for microneedling and energy-based devices.
A group of expert panelists gathered to discuss how social media can benefit your practice and how to best use it to your advantage.
Camp Wonder, a camp that supports kids with skin disease and is sponsored by Galderma, is celebrating their 20th year of operations this week.
BFI-751, Biofactura’s biosimilar drug to ustekinumab will be investigated for the first time on human patients.
BioPhotas announces the new addition to their Celluma light therapy device line, Celluma RESTORE, for the treatment of hair loss, aging skin, and general pain.
Cytrellis announced that the FDA has cleared the ellacor system to the treatment of moderate to severe wrinkles.
Twyneo, a tretinoin and benzoyl peroxide cream, has been approved by the FDA for the treatment of acne vulgaris in patients 9 years and older.
The newest FDA indication allows for greater distribution to younger but equally vulnerable immunocompromised patients.
A study from the Georgia Institute of Technology examined the difference of itch in hairy vs nonhairy skin.
The FDA has granted an orphan drug designation to alrizomadlin as a potential therapeutic option for patients with stage IIB-IV melanoma.
Dalbavancin has received FDA approval to treat acute bacterial skin and skin structure infections in pediatric patients.
Amgen and the International Federation of Psoriasis Associations have announced their efforts to combat the challenges of psoriasis.
Cartessa Aesthetics, LLC launched Physiq, its hands free, noninvasive body contouring device.
In this exclusive video interview, Christopher Bunick, MD, PhD, gives Dermatology Times an update on benzene contamination being detected in various sunscreens and after-sun care products, as well as a recent recall by Johnson & Johnson.
As COVID-19 eases, the FDA is breaking through its backlog and clinical trials are moving forward, opening the way for a new wave of treatments.
Here are best practices in understanding scar morphology, building patient trust, and choosing treatment.